Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PLBL | SRCE |
|---|---|---|
| Price | $5.67 | $86.26 |
| Change today | ▲ 0.35% | ▼ 0.68% |
| Market cap | $2.08B | $2.08B |
| Return, 3 months | -43.4% | +6.1% |
| Return, year to date | -48.3% | +40.4% |
| Return, 1 year | -30.9% | +45.0% |
| P/E (TTM) | -354.4 | 12.4 |
| P/B | -45.7 | 1.6 |
| P/E percentile vs own 5y | 28th | 94th |
| Dividend yield | – | 1.87% |
| Revenue growth (YoY, latest qtr) | -12.6% | +9.2% |
| Net profit growth (YoY) | +45.6% | +27.4% |
| Gross margin | 7.3% | – |
| Operating margin | -28.6% | – |
| Net margin | -22.6% | 40.2% |
| Return on equity | – | – |
| Analyst target vs. price | – | +8.4% |
| Analyst buy share | – | 50% |
| RSI (14) | 49 | 52 |
| 30-day volatility | 74.4% | 12.6% |
| Max drawdown, 1 year | -56.5% | -8.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
